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Abstract: The petroleum ether extract of Baccharis darwinii showed activity against 
Cryptococcus neoformans and dermatophytes. Bioactivity-guided fractionation of 
Baccharis darwinii has resulted in the isolation of three coumarins: 5’-hydroxy aurapten 
(anisocoumarin H, 1), aurapten (7-geranyloxycoumarin, 2) and 5’-oxoaurapten (diversinin, 
3). The structures of these compounds were characterized by spectroscopic methods. These 
compounds were evaluated for their antimicrobial activity against a panel of each, bacteria 
and fungi. Compound 3 showed the best activities against Microsporum gypseum, 
Trichophyton rubrum and Trichophyton mentagrophytes with MICs = 15.6 µg/mL, 
followed by compound 1 whose MICs against the same fungi were 62.5 µg/mL. In addition 
they showed fungicidal rather than fungistatic activity. Both compounds showed moderate 
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activity (MICs = 125 µg/mL) against Cryptococcus neoformans. This is the first report of 
the presence of compound 1 in B. darwinii. 




Currently, medicinal plants are widely used as home remedies or as alternative treatments by both 
rural and urban inhabitants in developing countries [1], which can be explained in part by the high cost 
of industrialized medicine. In turn, many extracts from plants have shown biological activities of 
interest, which justifies the search of potentially active compounds in them.  
A matter of concern in public health in the last decades is the increasing resistance of bacteria and 
fungus to antimicrobial drugs and the growing number of immunocompromised patients undergoing 
fatal fungal infections, since the available antifungals are scarce, sometimes ineffective and not  
always safe.  
The genus Baccharis L. possesses the highest number of species (between 400 and 500) within the 
Asteraceae family [2]. It was found only in American countries from the south of United States to the 
austral end of Argentina and Chile, occupying a great variety of environments. In the Argentine 
Republic, it is represented by 96 species [2], and among them, Baccharis darwinii, commonly known 
as “chilca”, can be found in the far south of South America that is, in the arid Patagonia region  
of Argentina . 
Several species of Baccharis genus are used in traditional medicine [3,4] for different ailments. 
Some species, known as “carquejas” (B. trimera, B. crispa, etc.) are used against hepatic disorders. 
Another species, known as “mio-mio” (B. coridifolia) is poisonous for livestock [5], while another, 
“mata-trigo” (B. gilliesii), is an invader of cultures.  
Studies on the biological activities of species of this genus have shown antimicrobial, antioxidant, 
anti-inflammatory and antifeedant activities [6-17]. Regarding the chemical constituents found in the 
genus, flavonoids and terpenoids are the most frequently reported [17-20]. Regarding B. darwinii, the 
presence of β-farnesene, aurapten, 5’-oxoaurapten, and 6’,7’-epoxy- and 6’,7’-dihydroxyaurapten were 
reported by Zdero et al. in a sample collected in the Argentinean Neuquén province [21]. Nevertheless, 
to the best of our knowledge there are no reports on the biological activities of Baccharis darwinii. We 
report here the antimicrobial activity of crude extracts of this plant collected in Chubut province, a 
southernmost province of Argentina, and the bioassay-guided fractionation of its most active extract 
which led to the isolation of the main compounds responsible for the activity.  
2. Results and Discussion 
In the first step of our work, we evaluated the antimicrobial (antibacterial and antifungal) activity of 
the petroleum ether (PE), dichloromethane (DCM) and methanol (MeOH) extracts from aerial parts of 
Baccharis darwinii. Regarding antibacterial activity of the different extracts, MeOH did not show any 
activity (MIC > 1,000 µg/mL), PE showed only marginal activity (MIC ≥ 1 ,000 µg/mL) and DCM 
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extract showed a very low activity against only two bacteria (MIC = 750 µg/mL) and marginal or null 
activity against the rest of bacteria of the panel. 
In contrast, the three extracts showed better antifungal activities, mainly against dermatophytes and, 
in addition, they were shown to possess not only fungistatic but also fungicidal capacity (Table 1). 
Nevertheless, some differences could be observed among the activity of the three extracts (Table 1): 
the PE and MeOH extracts were the most active extracts mainly against C. neoformans. Between them, 
PE extract showed four-fold higher potency than MeOH extract against the same fungi. Among the 
different extracts, PE is of great interest since it showed a selective and good activity against C. 
neoformans and dermatophytes. On the basis of these results, PE was submitted to fractionation guided 
by antifungal activity as described in the Experimental section.  
Table1. Antifungal and antibacterial activity to Baccharis darwinii extracts (MIC/MFC, µg/mL).  
Microorganisms Extracts Reference drugs 
Fungus PE DCM MeOH Amp B Ket Terb 
Candida albicans ATCC 10231 >1,000 >1,000 >1,000 1 0.5 - 
Candida tropicalis C 131 2000 >1,000 >1,000 >1,000 0.5 0.125 - 
Saccharomyces cerevisiae ATCC 9763 >1,000 >1,000 >1,000 0.5 0.5 - 
Cryptococcus neoformans ATCC 32264 125/250 >1,000 500/1,000 0.25 0.25 - 
Aspergillus flavus ATCC 9170 >1,000 >1,000 >1,000 0.5 0.125 - 
Aspergillus fumigatus  ATCC 26934 >1,000 >1,000 >1,000 0.5 0.25 - 
Aspergillus niger ATCC 9029 >1,000 >1,000 >1,000 0.5 0.5  
Microsporum gypseum C 115 2000 125/125 1,000/1,000 500/500 0.125 0.05 0.04 
Trichophyton rubrum C 113 2000 62.5/125 500/1,000 250/1,000 0.075 0.025 0.025 
Trichophyton mentagrophytes ATCC 9972 62.5/125 500/1,000 250/500 0.075 0.025 0.04 
(*) Reference substances: Amp B: Amphotericin B, Ket: Ketoconazole, Terb: Terbinafine. 
The nine sub-fractions obtained from PE extract (I-IX) were evaluated for antifungal properties 
against the same panel used for the crude extracts. Results (Table 2) showed that the best activity was 
displayed by sub-fraction VI against dermatophytes (MIC and MFC = 62.5 µg/mL). From this sub-
fraction for successive fractionations, three known coumarins: 5’-hydroxyaurapten (anisocoumarin H, 
1), aurapten (7-geranyloxycoumarin, 2) and 5’-oxoaurapten (diversinin, 3) were isolated and their 
antifungal activities were evaluated. Of these, 1 has not been reported previously in B. darwinii while 
2 and 3 have been reported previously in this plant [21]. The compounds were identified by 
comparison of their NMR data with literature vales (see Experimental). The corresponding structures 
are shown in Figure 1. 
It is interesting to note that two of these coumarins, 1 and 3, displayed antifungal activity against C. 
neoformans and dermatophytes (Table 2) and therefore both compounds would be the responsible for 
the antifungal activity observed in the PE extract of B. darwinii. Compound 3 possess a high 
fungistatic activity against the three dermatophytes tested, with MICs = 15.6 µg/mL and a fungicide 
capacity. This result is very interesting since T. rubrum and T. mentagrophytes are responsible for 
approximately 80–93% of chronic and recurrent dermatophytes infections in human beings. They are 
the ethiological agent of tinea unguium (producer of invasive nail infections), tinea manuum (palmar 
and interdigital areas of the hand infections) and tinea pedis (athlete’s foot), the last one being the most 
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prevalent fungal infection in developed countries, and the first one accounting for 50% and 90% of all 
fingernail and toenail infections respectively [22].  
Table 2. In vitro evaluation of the antifungal activity of different fractions resulted from 
Sephadex percolation of PE extracts and compounds 1-3 from B. darwinii (MIC/MFC 
values are given in μg/mL). 
Seph PE Fractions Ca Ct Sc Cn Mg Tr Tm 
Seph PE I-III > 250 > 250 > 250 > 250 > 250 > 250 > 250 
Seph PE IV > 250 > 250 > 250 > 250 250/250 250/250 250/250 
Seph PE V > 250 > 250 > 250 250/>250 62.5/62.5 62.5/125 62.5/125 
Seph PE VI > 250 > 250 > 250 250/> 250 62.5/62.5 62.5/62.5 62.5/62.5 
Seph PE VII > 250 > 250 > 250 250/> 250 125/250 125/250 125/250 
Seph PE VIII > 250 > 250 > 250 250/>250 250 / 250 250/>250 250/>250 
Seph PE IX > 250 > 250 > 250 >250 > 250 >250 >250 
Compounds        
1 > 250 > 250 > 250 125 62.5/125 62.5/62.5 62.5/62.5 
2 > 250 > 250 > 250 > 250 > 250 > 250 > 250 
3 > 250 > 250 > 250 125 15.6/125 15.6/125 15.6/125 
Reference drugs        
Amphotericin B 0.25 0.25 1 0.50 0.12 0.07 0.07 
Ketoconazole 0.25 0.25 0.50 0.50 0.04 0.02 0.02 
Terbinafine     0.04 0.01 0.04 
Ca: Candida albicans ATCC 10231; Ct: Candida tropicalis C 131; Sc: Saccharomyces cerevisiae 
ATCC 9763; Cn: Cryptococcus neoformans ATCC 32264; Mg: Microsporum gypseum C 115; Tr: 
Trichophyton rubrum C113; Tm: Trichophyton mentagrophytes ATCC 9972. 
 




































In turn, although the activity displayed by 1 and 3 against C. neoformans (MIC = 125 µg/mL) is 
moderate, it is worthy to take into account that C. neoformans remains an important life-threatening 
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complication for immunocompromised hosts, particularly for patients who have undergone 
transplantation of solid organs and, therefore, new compounds acting against this fungus are highly 
welcome [23]. The antimicrobial activity is considered very interesting in the case of MICs < 100 µg 
mL-1 for extracts and 10 µg mL-1 for isolated compounds [24]. Another interesting contribution of this 
work is that, since the three coumarins have been previously isolated from other species, such as 
anisocoumarin H (1) in Clausena anisata [25] and Notopterygium forbesii [26]; auraptene (2) in 
Ferulago capillaris [27], Paliurus ramosissimus [28]; diversinin (3) in Ferula diversivittata [29], this 
work encourages the beginning of antifungal studies of these species in order to evaluate their 
antifungal potentiality.  
3. Experimental 
3.1. General 
IR spectra were recorded in a FTIR Shimadzu Prestige-21 instrument; 1D and 2D NMR spectra 
were recorded using a Bruker Avance 300 in deuterated chloroform solutions, using standard Bruker 
software. GC-MS were run in a Perkin Elmer Autosystem XL Gas Chromatograph coupled to a Turbo 
Mass Spectrometer. Column: SE-30, 25 m × 0.22 mm ID, Scientific Glass Engineering (Ringwood, 
Victoria, Australia).  
3.2. Plant material 
Aerial parts of Baccharis darwinii were collected at Comodoro Rivadavia, Chubut Province, 
Argentina at 45º 48' 34.5” Latitude (S) and 67º 26' 44” Longitude (O) in October 2007. The plant was 
identified by Prof. María Elena Arce, FCN, UNPSJB. A voucher specimen was deposited at Herbario 
Regional Patagónico (HRP 6154), Comodoro Rivadavia, Chubut, Argentina. 
3.3. Extraction 
The dried powdered aerial parts (450 g) were extracted successively with petroleum ether (PE), 
dichloromethane (DCM) and methanol (MeOH) at room temperature (3 × 1,000 mL, for 96 h each 
time). After evaporation to dryness under reduced pressure, PE, DCM and MeOH extracts were 
obtained in yields (w/w in terms of dry starting material) of 3.46%, 2.26% and 14,14%, respectively.  
3.4. Isolation 
A representative sample from PE bioactive extract (13.13 g) was applied to a Sephadex LH-20 
column (column length 37 cm, diameter 4 cm) equilibrated with: PE:MeOH:CHCl3 (2:1:1). After TLC 
comparison (silica gel, EtOAc:PE 2:8, as the mobile phase; detection under UV light followed by 
spraying with p-anisaldehyde), nine fractions were obtained: I: (0.2076 g), II: 1.1049 g, III: 1.2438 g, 
IV: 2.6301 g, V: 0.9964 g, VI: 3.6209 g, VII: 0.4913 g, VIII: 0.0180 g, IX: 0.0936 g. 
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3.4.1. Pooled fraction VI 
Fraction VI (3 g) was applied to a Sephadex LH-20 column (column length 37 cm, diameter 4 cm) 
equilibrated with: PE:MeOH:CHCl3 (2:1:1). After TLC comparison (silica gel, EtOAc:PE 2:8 as the 
mobile phase; detection under UV light followed by spraying with p-anisaldehyde), fractions were 
combined affording fifteen new fraction: VI1: 0.0022 g, VI2: 0.0034 g, VI3: 0.0113 g, VI4: 0.0209 g, 
VI5: 0.0436 g, VI6: 0.1155 g, VI7: 0.2904 g, VI8: 0.4154 g, VI9: 0.4587 g, VI10: 0.4793 g, VI11: 0.4424 
g, VI12: 0.3260 g, VI13: 0.1543 g, VI14: 0.1015 g, VI15: 0.091g. From fractions VI12-VI15 pure 
compound 1 (91.6 mg) was obtained. 
The potent bioactive antifungal fractions VI7– VI11 (749.2 mg) were applied onto a medium 
pressure chromatography column (MPCC, column length 60 cm, diameter 2 cm) containing 75 g silica 
gel (0.063-0.2 mesh, Merck 60) and eluted with 150 mL of cyclohexane-EtOAc 100:100 v/v. Some 
350 fractions of 10 mL each were obtained. From fractions 44-64 pure compound 2 (72.6 mg) was 
obtained whereas from fractions 150-158 yielded mainly compound 3 (100.9 mg). 
3.5. Isolated compounds 
7-(5-Hydroxy-3,7-dimethylocta-2,6-dienyloxy)-chromen-2-one (5’-hydroxy aurapten, 1). The NMR 
data were in agreement with those reported by Ngadjui et al. [25]. 
7-(3,7-Dimethylocta-2,6-dienyloxy)-chromen-2-one (aurapten, 2). The NMR data were in agreement 
with those reported by Zdero et al. [21]. 
7-(3,7-Dimethyl-5-oxoocta-2,6-dienyloxy)-chromen-2-one (5’-oxoaurapten, 3). The NMR data were in 
agreement with those reported by Zdero et al. [21]. 
 
3.6. Antimicrobial activity 
3.6.1. Microorganisms and media 
For the antibacterial evaluation, strains from the American Type Culture Collection (ATCC) 
Rockville MD (USA), Malbrán Institute (MI), Pasteur Institute (PI) and from the Laboratorio de 
Microbiología (LM, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, 
Argentina) were used: Escherichia coli ATCC 25922, LM1-Escherichia coli, LM2-Escherichia coli, 
Pseudomonas aeruginosa ATCC 27853, LM-Salmonella sp., MI-Salmonella enteritidis, PI-Yersinia 
enterocolítica, Staphylococcus aureus methicillin-sensitive ATCC 29213 and Staphylococcus aureus 
methicillin-resistant ATCC 43300. Bacteria were grown on Müeller–Hinton agar medium. 
For the antifungal evaluation, strains from the American Type Culture Collection (ATCC), 
Rockville, MD, USA and CEREMIC (C), Centro de Referencia en Micología, Facultad de Ciencias 
Bioquímicas y Farmacéuticas, Suipacha 531, 2000 Rosario, Argentina, were used: Candida albicans 
ATCC10231, Candida tropicalis C131, Saccharomyces cerevisiae ATCC9763, Cryptococcus 
neoformans ATCC32264, Aspergillus flavus ATCC9170, Aspergillus fumigatus ATTC26934, 
Aspergillus niger ATCC9029, Trichophyton rubrum C110, Trichophyton mentagrophytes ATCC9972 
and Microsporum gypseum C115. Strains were grown on Sabouraud-chloramphenicol agar slants for 
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48 h at 30 ºC, maintained on slopes of Sabouraud-dextrose agar (SDA, Oxoid) and sub-cultured every 
15 days to prevent pleomorphic transformations. Inocula were obtained according to reported 
procedures [30] and adjusted to 1–5 × 103 cells/spores with colony forming units (CFU) /mL  
3.6.2. Antibacterial susceptibility testing 
Cultures less than 30 h old were touched with a loop and transferred to sterile Mueller-Hinton broth. 
The broth was incubated at 37 ºC until the growth reaches turbidity equal to, or greater than that of 0.5 
Mc Farland standards. The culture was adjusted with sterile physiological solution to give final 
organism density of 5 × 105 CFU/mL [31, 32]. The antibacterial activity was evaluated with the agar 
dilution method using Mueller Hinton agar medium for Gram (+) and Gram (-) bacteria. Stock 
solutions of the compounds/extracts in DMSO were diluted to give serial two-fold dilutions that were 
added to each medium resulting in concentrations ranging from 10 to 1,000 µg/mL. The final 
concentration of DMSO in the assay did not exceed 1%. The antimicrobial agent cefotaxime (Argentia 
Pharmaceutica) was included in the assays as positive control. The plates were incubated for 24 h at  
37 ºC. Minimum Inhibitory Concentration (MIC) was defined as the lowest compounds/extracts 
concentration showing no visible bacterial growth after incubation time. Tests were carried out in 
triplicate. Extracts and compounds with MICs ≤ 250 µg/mL were considered of interest.  
3.6.3. Antifungal susceptibility testing 
Minimum Inhibitory Concentration (MIC) of each extract or compound was determined by using 
broth microdilution techniques according to the guidelines of the Clinical and Laboratory Standards 
Institute (CLSI, formerly National Committee for Clinical and Laboratory Standards, NCCLS) for 
yeasts (M27-A2) and for filamentous fungi (M 38 A), [30]. MIC values were determined in RPMI-
1640 (Sigma, St Louis, MO, USA) buffered to pH 7.0 with MOPS. Microtiter trays were incubated at 
35 ºC for yeasts and hialohyphomycetes and at 28–30 ºC for dermatophyte strains in a moist, dark 
chamber. MICs were visually recorded at 48 h for yeasts, and at a time according to the control fungus 
growth, for the rest of fungi. Extracts with MICs ≤ 1 ,000 µg/mL and sub-extracts and compounds with 
MICs ≤ 250 µg/mL were considered active. 
For the assay, stock solutions of pure compounds were two-fold diluted with RPMI from 1,000 or 
250 µg/mL to 0.98 (final volume = 100 µL) and a final DMSO concentration ≤ 1%. A volume of 100 
µL of inoculum suspension was added to each well with the exception of the sterility control where 
sterile water was added to the well instead. Ketoconazole (Sigma Chem. Co.), terbinafine (Novartis, 
Argentina) and amphotericin B (Sigma Chem. Co.), were used as positive controls. Endpoints were 
defined as the lowest concentration of drug resulting in total inhibition (MIC100) of visual growth 
compared to the growth in the control wells containing no antifungal.  
The Minimum Fungicidal Concentration (MFC) of each extract or compound was determined as 
follows: After determining the MIC, an aliquot of 5 µL sample was withdrawn from each clear well of 
the microtiter tray and plated onto a 150-mm RPMI-1640 agar plate buffered with MOPS (Remel, 
Lenexa, Kans.). Inoculated plates were incubated at 30 ºC, and MFCs were recorded after 48 h. The 
MFC was defined as the lowest concentration of each compound that resulted in total inhibition of 
visible growth in these plates. 
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4. Conclusions 
Phytochemical study of B. darwinii extracts, bioguided by the antifungal assay, led to the isolation 
of the known prenylated coumarins 5’-hydroxyaurapten (1), aurapten (2) and 5’-oxoaurapten (3). This 
is the first report of the presence of compound 1 in B. darwinii. Among the three isolated compounds 
compound 3 showed the best activities against M. gypseum, T. rubrum and T. mentagrophytes with 
MICs = 15.6 µg/mL, followed by compound 1 whose MICs against the same fungi were 62.5 µg/mL. 
In addition their activity was shown to be fungicidal rather than fungistatic. Both compounds showed 
moderate activity (MICs = 125 µg/mL) against C. neoformans.  
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